{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:05:25Z","timestamp":1790366725643,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcjd.2026.05.004","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:20:38Z","timestamp":1779466838000},"page":"423-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world Glycemic Outcomes of a Tubeless Automated Insulin Delivery System (Medtrum A8 TouchCare) in Adults With Type 1 Diabetes"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7783-3512","authenticated-orcid":false,"given":"Michele Roberto","family":"Modestino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"De Fortuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ferrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Verdoliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Foglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Guardasole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.05.004_bib1","first-page":"S146","article-title":"Diabetes technology: Standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.05.004_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/dom.14273","article-title":"Hybrid closed-loop therapy: Where are we in 2021?","volume":"23","author":"Leelarathna","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2026.05.004_bib3","first-page":"339","article-title":"Barriers to uptake of insulin technologies and novel solutions","volume":"14","author":"Pauley","year":"2021","journal-title":"Med Devices (Auckl)"},{"key":"10.1016\/j.jcjd.2026.05.004_bib4","volume":"7","author":"Cyranka","year":"2023","journal-title":"JMIR Form Res"},{"key":"10.1016\/j.jcjd.2026.05.004_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/dc16-1536","article-title":"Diabetes device use in adults with type 1 diabetes: Barriers to uptake and potential intervention targets","volume":"40","author":"Tanenbaum","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.05.004_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1089\/dia.2023.0578","article-title":"Real-world evidence of Omnipod\u00ae 5 automated insulin delivery system use in 69,902 people with type 1 diabetes","volume":"26","author":"Forlenza","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.05.004_bib7","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.2337\/dc24-1550","article-title":"Efficacy and safety of a tubeless AID system compared with pump therapy with CGM in the treatment of type 1 diabetes in adults with suboptimal glycemia: A randomized, parallel-group clinical trial","volume":"47","author":"Renard","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.05.004_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109858","article-title":"Patch Pumps: What are the advantages for people with diabetes?","volume":"187","author":"Kulzer","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2026.05.004_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5152\/erp.2025.24618","article-title":"Early stage effectiveness of the automated insulin delivery system\u2014Is artificial intelligence really effective?","volume":"29","author":"Cetin","year":"2025","journal-title":"ERP"},{"key":"10.1016\/j.jcjd.2026.05.004_bib12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.05.004_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/15209156251380593","article-title":"Improving time-in-range in type 1 diabetes: Projecting the clinical and cost implications of automated insulin delivery","volume":"28","author":"Hussain","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.05.004_bib14","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00125-024-06171-y","article-title":"The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: A retrospective cross-sectional real-world study","volume":"67","author":"De Meulemeester","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2026.05.004_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/dia.2020.0501","article-title":"HbA1c and glucose management indicator discordance: A real-world analysis","volume":"23","author":"Perlman","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.05.004_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/dc23-1355","article-title":"A multicenter prospective evaluation of the benefits of two advanced hybrid closed-loop systems in glucose control and patient-reported outcomes in a real-world setting","volume":"47","author":"Beato-V\u00edbora","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.05.004_bib17","doi-asserted-by":"crossref","DOI":"10.2174\/1573399820666230531161858","article-title":"Comparison of the sensor-augmented pump system with the advanced hybrid closed-loop delivery system: Quality of life, diabetes distress, and glycaemic outcomes in a real-life context","volume":"20","author":"Benioudakis","year":"2024","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jcjd.2026.05.004_bib18","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.2337\/dc22-1217","article-title":"Biobehavioral changes following transition to automated insulin delivery: A large real-life database analysis","volume":"45","author":"Kovatchev","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.05.004_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12902-022-00996-7","article-title":"Glycemic outcomes of advanced hybrid closed loop system in children and adolescents with type 1 diabetes, previously treated with multiple daily injections (MiniMed 780G system in T1D individuals, previously treated with MDI)","volume":"22","author":"Petrovski","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jcjd.2026.05.004_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1089\/dia.2023.0123","article-title":"Glycemic outcomes during early use of the MiniMed\u2122 780G advanced hybrid closed-loop system with Guardian\u2122 4 sensor","volume":"25","author":"Cordero","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.05.004_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/dia.2018.0138","article-title":"Performance of the Omnipod personalized model predictive control algorithm with meal bolus challenges in adults with type 1 diabetes","volume":"20","author":"Buckingham","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"Suppl. 3","key":"10.1016\/j.jcjd.2026.05.004_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/dia.2023.0442","article-title":"Real-world evidence of automated insulin delivery system use","volume":"26","author":"Considine","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.05.004_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1099024","article-title":"One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes","volume":"14","author":"Bassi","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2026.05.004_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/dia.2017.0416","article-title":"Metrics to evaluate quality of glycemic control: Comparison of time in target, hypoglycemic, and hyperglycemic ranges with \u201crisk indices.\u201d","volume":"20","author":"Rodbard","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.05.004_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s40001-024-01946-w","article-title":"Impact on glycemia risk index and other metrics in type 1 adult patients switching to advanced hybrid closed-loop systems: A one-year real-life experience","volume":"29","author":"Resmini","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jcjd.2026.05.004_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/dia.2023.0112","article-title":"The advanced hybrid closed loop improves glycemia risk index, continuous glucose monitoring index, and time in range in children with type 1 diabetes: Real-world data from a single center study","volume":"25","author":"Eviz","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.05.004_bib27","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s40618-025-02609-1","article-title":"Glycemia risk index (GRI): A metric designed to facilitate the interpretation of continuous glucose monitoring data: A narrative review","volume":"48","author":"Oriot","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jcjd.2026.05.004_bib28","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1177\/19322968231164151","article-title":"Glycemic risk index profiles and predictors among diverse adults with type 1 diabetes","volume":"18","author":"Hoogendoorn","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jcjd.2026.05.004_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00592-024-02381-3","article-title":"Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: A multicenter, real-world observational study","volume":"62","author":"Molfetta","year":"2025","journal-title":"Acta Diabetol"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S149926712600095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S149926712600095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:53:52Z","timestamp":1790366032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S149926712600095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S149926712600095X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2026.05.004","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world Glycemic Outcomes of a Tubeless Automated Insulin Delivery System (Medtrum A8 TouchCare) in Adults With Type 1 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2026.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published on behalf of Diabetes Canada.","name":"copyright","label":"Copyright"}]}}